Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 7
June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
ID3/LRRK1 is a novel limbal epithelial stem cell regulatory axis
Author Affiliations & Notes
  • Han Peng
    Dermatology, Northwestern University, Chicago, Illinois, United States
  • Junyi Wang
    Dermatology, Northwestern University, Chicago, Illinois, United States
    Ophthalmology, Chinese PLA General Hospital, Beijing, China
  • Wending Yang
    Dermatology, Northwestern University, Chicago, Illinois, United States
  • Nihal Kaplan
    Dermatology, Northwestern University, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   Han Peng, None; Junyi Wang, None; Wending Yang, None; Nihal Kaplan, None
  • Footnotes
    Support  EY028560, EY019463, Dermatology Foundation , Eversight Eye Bank research grants
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 2796. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Han Peng, Junyi Wang, Wending Yang, Nihal Kaplan; ID3/LRRK1 is a novel limbal epithelial stem cell regulatory axis. Invest. Ophthalmol. Vis. Sci. 2020;61(7):2796.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Limbal epithelial stem cells (LESCs) play key roles in corneal epithelial homeostasis. When LESCs are compromised, delayed wound healing and persistent corneal epithelial defects often occur. Transplantation of ex vivo limbal epithelial cultures has been used to treat LESC deficiency and the success rate is significantly associated with the numbers of LESCs in the ex vivo cultures. Therefore, it is clinically significant to understand the signaling pathways that are central for maintenance of stem cells and which could be pharmacologically targeted to enhance ex vivo LESC viability.

Methods : To elucidate novel signaling pathways involved in LESC homeostasis, single cell RNA (scRNA) seq was used to transcriptionally analyze the rare population of limbal stem/early TA epithelial cells. Gene expression was validated using immunoblotting, qPCR and immunostaining. For functional studies, gene expression was silenced via siRNA knockdown and knockout mouse models. Diet-induced obesity (DIO) mice and Akita mice were used as diabetic mouse models.

Results : ScRNA seq and immunostaining revealed that ID3, a key regulator for maintaining stemness in several non-ocular tissues, was preferentially expressed in the stem/early TA population of limbal epithelium. Loss of ID3 in human limbal epithelial cells markedly reduced the expression of putative LESC markers (e.g., N-cad, ABCB5). In the limbal epithelium of diabetic patients, as well as the DIO and Akita mice, we observed a reduction of ID3 expression, which was accompanied by a depletion in LESCs. This suggests that loss of ID3 may contribute to the LESC defect reported in diabetic corneas. RNA seq, immunostaining and biochemistry revealed that leucine rich repeat kinase 1 (LRRK1), which is preferentially expressed in limbal epithelium, positively regulates ID3 expression in vitro and in vivo. Similar to ID3, loss of LRRK1 diminished the expression of putative LESC markers and altered the ability of LESCs to respond to corneal epithelial wounding in mice.

Conclusions : Our findings indicate that ID3/LRRK1 forms a novel signaling axis, which plays a critical role in maintenance of LESCs. Delivery of ID3 mRNA via nanotechnology has therapeutic potential to preserve stem cells in ex vivo limbal epithelial cultures.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×